Cargando…
Novel efficacious microRNA-30c analogs reduce apolipoprotein B secretion in human hepatoma and primary hepatocyte cells
High plasma lipid levels have been demonstrated to increase cardiovascular disease risk. Despite advances in treatments to decrease plasma lipids, additional therapeutics are still needed because many people are intolerant or nonresponsive to these therapies. We previously showed that increasing cel...
Autores principales: | Yadav, Pradeep Kumar, Haruehanroengra, Phensinee, Irani, Sara, Wang, Ting, Ansari, Abulaish, Sheng, Jia, Hussain, M. Mahmood |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Biochemistry and Molecular Biology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8980335/ https://www.ncbi.nlm.nih.gov/pubmed/35278429 http://dx.doi.org/10.1016/j.jbc.2022.101813 |
Ejemplares similares
-
MicroRNA-30c reduces hyperlipidemia and atherosclerosis by decreasing lipid synthesis and lipoprotein secretion
por: Soh, James, et al.
Publicado: (2013) -
Sortilin restricts secretion of apolipoprotein B-100 by hepatocytes under stressed but not basal conditions
por: Conlon, Donna M., et al.
Publicado: (2022) -
Supplementary site interactions are critical for the regulation of microsomal triglyceride transfer protein by microRNA-30c
por: Soh, James, et al.
Publicado: (2013) -
The effects of short‐chain fatty acids on the transcription and secretion of apolipoprotein A‐I in human hepatocytes in vitro
por: Tayyeb, Jehad Z., et al.
Publicado: (2019) -
Inhibition of vitamin D analog eldecalcitol on hepatoma in vitro and in vivo
por: Ye, Limin, et al.
Publicado: (2020)